查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1413126

神经血管介入器材市场：按产品、工艺、疾病病理、治疗应用和最终用途 - 2024-2030 年全球预测

Neurovascular Intervention Devices Market by Product, Process, Disease Pathology, Therapeutic Applications, Application, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年神经血管介入器材市场规模为37.5亿美元，预估2024年将达39.5亿美元，2030年将达58.3亿美元，复合年增长率为6.47%。

全球神经血管介入器材市场

主要市场统计
基准年[2023] 37.5亿美元
预测年份 [2024] 39.5亿美元
预测年份 [2030] 58.3亿美元
复合年增长率（%） 6.47%
神经血管介入设备市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估神经血管介入器材市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对神经血管介入器材市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-神经血管介入器材市场的市场规模与预测是多少？

2-神经血管介入器材市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-神经血管介入器材市场的技术趋势和法律规范是什么？

4-神经血管介入器材市场主要供应商的市场占有率是多少？

5-进入神经血管介入器材市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对有效神经血管设备的需求不断增长
      • 政府致力于现代化和扩大新兴市场的医疗基础设施
      • 提高成熟经济体的医疗薪酬
    • 抑制因素
      • 神经血管介入器材相关的严格监管场景
    • 机会
      • 神经血管治疗领域的研究数量不断增加
      • 提升神经外科医师对微创手术的认识
    • 任务
      • 缺乏熟练的神经外科医生
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章神经血管介入器材市场：副产品

  • 气球系统
  • 颈动脉支架
  • 导管
  • 栓塞圈
  • 栓塞保护装置
  • 分流器
  • 导管导引线
  • 颅内支架
  • 囊内装置
  • 神经血栓切除装置
  • 支架回收器

第七章神经血管介入器材市场：依流程

  • 颈动脉切除术
  • 脑血管血管造影术
  • 卷绕
  • 分流
  • 显微外科夹闭
  • 神经血栓切除术
  • 支架置入术

第八章依疾病病理分类的神经血管介入器材市场

  • 动静脉畸形和瘻管
  • 颈动脉狭窄
  • 脑动脉瘤
  • 缺血性中风

第九章依治疗应用分類的神经血管介入器材市场

  • 脑动脉瘤
  • 缺血性中风
  • 收缩

第10章神经血管介入设备市场：依应用分类

  • 动静脉畸形
  • 颅内动脉瘤
  • 缺血性中风

第十一章神经血管介入器材市场：依最终用途分类

  • 门诊手术中心
  • 医院

第十二章美洲神经血管介入器材市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太神经血管介入器材市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章欧洲、中东、非洲神经血管介入器材市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第16章竞争组合

  • 主要公司简介
    • Abbott Laboratories
    • Acandis GmbH
    • Boston Scientific Corporation
    • Evasc Medical Systems Corp.
    • Johnson & Johnson Services, Inc.
    • LivaNova PLC
    • Medikit Co., Ltd.
    • Medtronic PLC
    • Microport Scientific Corporation
    • Penumbra, Inc.
    • Phenox GmbH
    • Rapid Medical Ltd.
    • Stryker Corporation
    • Terumo Corporation
  • 主要产品系列

第十七章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-ED54C46E8FB5

[180 Pages Report] The Neurovascular Intervention Devices Market size was estimated at USD 3.75 billion in 2023 and expected to reach USD 3.95 billion in 2024, at a CAGR 6.47% to reach USD 5.83 billion by 2030.

Global Neurovascular Intervention Devices Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.75 billion
Estimated Year [2024] USD 3.95 billion
Forecast Year [2030] USD 5.83 billion
CAGR (%) 6.47%
Neurovascular Intervention Devices Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Neurovascular Intervention Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neurovascular Intervention Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Intervention Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Boston Scientific Corporation, Evasc Medical Systems Corp., Johnson & Johnson Services, Inc., LivaNova PLC, Medikit Co., Ltd., Medtronic PLC, Microport Scientific Corporation, Penumbra, Inc., Phenox GmbH, Rapid Medical Ltd., Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Neurovascular Intervention Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Balloon Systems
    • Carotid Stents
    • Catheters
    • Embolic Coils
    • Embolic Protection Devices
    • Flow Diverters
    • Guidewires
    • Intracranial Stents
    • Intrasaccular Devices
    • Neurothrombectomy Devices
    • Stent Retrievers
  • Process
    • Carotid Endarterectomy
    • Cerebral Angiography
    • Coiling
    • Flow Diversion
    • Microsurgical Clipping
    • Neurothrombectomy
    • Stenting
  • Disease Pathology
    • Arteriovenous Malformations & Fistulas
    • Carotid Artery Stenosis
    • Cerebral Aneuryms
    • Ischemic Strokes
  • Therapeutic Applications
    • Brain Aneurysm
    • Ischemic Strokes
    • Stenosis
  • Application
    • Arteriovenous Malformation
    • Intracranial Aneurysm
    • Ischemic Stroke
  • End-use
    • Ambulatory Surgical Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Neurovascular Intervention Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neurovascular Intervention Devices Market?

3. What are the technology trends and regulatory frameworks in the Neurovascular Intervention Devices Market?

4. What is the market share of the leading vendors in the Neurovascular Intervention Devices Market?

5. Which modes and strategic moves are suitable for entering the Neurovascular Intervention Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Neurovascular Intervention Devices Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for effective neurovascular devices
      • 5.1.1.2. Government initiatives to modernize and expand healthcare infrastructure across emerging markets
      • 5.1.1.3. Improvements in medical reimbursement in mature economies
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory scenario associated with neurovascular intervention devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising number of researches in the field of neurovascular therapies
      • 5.1.3.2. Growing awareness among neurosurgeons about minimally invasive surgical procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled neurosurgeons
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Neurovascular Intervention Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Balloon Systems
  • 6.3. Carotid Stents
  • 6.4. Catheters
  • 6.5. Embolic Coils
  • 6.6. Embolic Protection Devices
  • 6.7. Flow Diverters
  • 6.8. Guidewires
  • 6.9. Intracranial Stents
  • 6.10. Intrasaccular Devices
  • 6.11. Neurothrombectomy Devices
  • 6.12. Stent Retrievers

7. Neurovascular Intervention Devices Market, by Process

  • 7.1. Introduction
  • 7.2. Carotid Endarterectomy
  • 7.3. Cerebral Angiography
  • 7.4. Coiling
  • 7.5. Flow Diversion
  • 7.6. Microsurgical Clipping
  • 7.7. Neurothrombectomy
  • 7.8. Stenting

8. Neurovascular Intervention Devices Market, by Disease Pathology

  • 8.1. Introduction
  • 8.2. Arteriovenous Malformations & Fistulas
  • 8.3. Carotid Artery Stenosis
  • 8.4. Cerebral Aneuryms
  • 8.5. Ischemic Strokes

9. Neurovascular Intervention Devices Market, by Therapeutic Applications

  • 9.1. Introduction
  • 9.2. Brain Aneurysm
  • 9.3. Ischemic Strokes
  • 9.4. Stenosis

10. Neurovascular Intervention Devices Market, by Application

  • 10.1. Introduction
  • 10.2. Arteriovenous Malformation
  • 10.3. Intracranial Aneurysm
  • 10.4. Ischemic Stroke

11. Neurovascular Intervention Devices Market, by End-use

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Hospitals

12. Americas Neurovascular Intervention Devices Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Neurovascular Intervention Devices Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Neurovascular Intervention Devices Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. FPNV Positioning Matrix
  • 15.2. Market Share Analysis, By Key Player
  • 15.3. Competitive Scenario Analysis, By Key Player

16. Competitive Portfolio

  • 16.1. Key Company Profiles
    • 16.1.1. Abbott Laboratories
    • 16.1.2. Acandis GmbH
    • 16.1.3. Boston Scientific Corporation
    • 16.1.4. Evasc Medical Systems Corp.
    • 16.1.5. Johnson & Johnson Services, Inc.
    • 16.1.6. LivaNova PLC
    • 16.1.7. Medikit Co., Ltd.
    • 16.1.8. Medtronic PLC
    • 16.1.9. Microport Scientific Corporation
    • 16.1.10. Penumbra, Inc.
    • 16.1.11. Phenox GmbH
    • 16.1.12. Rapid Medical Ltd.
    • 16.1.13. Stryker Corporation
    • 16.1.14. Terumo Corporation
  • 16.2. Key Product Portfolio

17. Appendix

  • 17.1. Discussion Guide
  • 17.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NEUROVASCULAR INTERVENTION DEVICES MARKET DYNAMICS
  • FIGURE 7. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 10. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2030 (%)
  • FIGURE 12. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2023 VS 2030 (%)
  • FIGURE 14. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 16. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 18. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 22. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 27. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 28. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 18. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS & FISTULAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ARTERY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 31. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BRAIN ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 144. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 150. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 169. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 175. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 181. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 187. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 193. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 199. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 205. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 217. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 223. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 229. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 235. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 259. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 263. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 264. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 265. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 275. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 276. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 277. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 291. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 292. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 293. NEUROVASCULAR INTERVENTION DEVICES MARKET LICENSE & PRICING